LONDON, UK: ConvaTec Group has entered into a definitive agreement to acquire Triad Life Sciences Inc, a US-focused medical device company that develops biologically-derived innovative products to address unmet clinical needs in surgical wounds, chronic wounds and burns. The initial consideration is $125 million with two potential additional payments of $25 million each relating to…